Principles of enzyme-inhibitor design

Protein-Ligand Interactions: From Molecular Recognition to Drug Design

Volumn , Issue , 2005, Pages 163-185

  Banner, David W ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Active site; de novo design of inhibitors; Drug design; Enzyme inhibitor design; Inhibitors; Progressive design; Structure activity relationships (SAR); Thrombin inhibitors

Indexed keywords

ENZYME INHIBITORS;

HUMAN COMPUTER INTERACTION;

EID: 84969528333     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527601813.ch7     Document Type: Chapter

References (80)

1. Wiley, M.R. and Fisher, M. J., Exp. Opin. Ther. Pat., 1997, 7(11), 1265-1282.
2. Coburn, C. A., Expert Opin. Ther. Pat., 2001, 11(5), 721-738.
3. Anand, S., Haemostasis, 1999, 29 (Suppl. 1), 76-78.
4. French, J. K. and White, H.D., Curr. Card. Rep., 1999, 1(3), 184-191.
5. Gustafsson, D., et al., Thrombosis Res., 2001, 101(3), 171-181.
6. Hauptmann, J., Nova Acta Leopold., 1999, 80(311), 61-82.
7. Hauptmann, J. and Sturzebecher, J., Thromb. Res., 1999, 93(5), 203-241.
8. Hauptmann, J., Eur. J. Clin. Pharmacol., 2002, 57(11), 751-758.
9. Hirsh, J., Am. Heart J., 2001. 142(2, Suppl.), S3-S8.
10. Menear, K, Expert Opin. Invest. Drugs, 1999, 8(9), 1373-1384.
11. Shen, G.X., Curr. Drug Targets: Cardiovasc. & Haematol. Disord., 2001, 1(1), 41-49.
12. Schechter, I. and Berger, A., Biochem. Biophys. Res. Commun., 1968, 32(5), 898-902.
13. Banner, D.W. and Hadvary, P., J. Biol. Chem., 1991, 266(30), 20085-20093.
14. Wilkinson, A. S., et al., Biochemistry, 1999, 38(13), 3851-3856.
15. Chittock, R. S., et al., Biochem. J., 1999, 338(Pt 1), 153-159.
16. Marquart, M., et al., Acta Cryst., 1983, B39, 480-490.
17. Banner, D.W., Nature, 2000, 404(6777), 449-450.
18. Kettner, C. and Shaw, E., Thrombosis Res., 1979, 14(6), 969-973.
19. Mattos, C., et al., Biochemistry, 1995, 34(10), 3193-3203.
20. Ding, X., et al., Biochemistry, 1994, 33(31), 9285-9293.
21. Ding, X., et al., Biochemistry, 1995, 34(23), 7749-7756.
22. Mattos, C., et al., Nat. Struct. Biol., 1994, 1(1), 55-58.
23. Peisach, E., et al., Science, 1995, 269(5220), 66-69.
24. Katona, G., et al., J. Biol. Chem., 2002, 14, 14.
25. Skordalakes, E., et al., J. Mol. Biol., 2001, 311(3), 549-555.
26. Bohm, H.J., D.W. Banner, and Weber, L., J. Comput. Aided Mol. Des., 1999, 13(1), 51-56.
27. Bohm, H.J., J. Mol. Recognit., 1993, 6(3), 131-137.
28. Hilpert, K., et al., J. Med. Chem., 1994, 37(23), 3889-3901.
29. Weber, L., et al., Angew. Chem. Int. Ed. Engl., 1995, 107, 2453-2454.
30. Illgen, K., et al., Chem. Biol., 2000, 7(6), 433-441.
31. Verlinde, C. L. and Hol, W. G., Structure, 1994, 2(7), 577-587.
32. Hart, P. A. and Rich, D.H., Pract. Med. Chem., 1996, 393-412.
33. Rich, D. H., Perspect. Med. Chem. 1993, 15-25.
34. Kikumoto, R., et al., Biochemistry, 1984, 23(1), 85-90.
35. Brandstetter, H., et al., J. Mol. Biol., 1992, 226(4), 1085-1099.
36. Sturzebecher, J., et al., Thromb. Res., 1983, 29(6), 635-642.
37. Obst, U., et al., Angew. Chem. Int. Ed. Engl., 1995, 34, 1739-1742.
38. Obst, U., et al., Chem. Biol., 1997, 4(4), 287-295.
39. Weber, I. R., et al., Bioorg. Med. Chem. Lett., 1998, 8(13), 1613-1618.
40. Lu, T., et al., Bioorg. Med. Chem. Lett., 1998, 8(13), 1595-1600.
41. Lu, T., et al., Bioorg. Med. Chem. Lett., 2000, 10(1), 83-85.
42. Lu, T., et al., Bioorg. Med. Chem. Lett., 2000, 10(1), 79-82.
43. Bone, R., et al., J. Med. Chem., 1998, 41(12), 2068-2075.
44. von der Saal, W., et al., Bioorg. Med. Chem. Lett., 1997, 7(10), 1283-1288.
45. Engh, R. A., et al., Structure, 1996, 4(11), 1353-1362.
46. Bergner, A., et al., J. Enzyme Inhib., 1995, 9(1), 101-110.
47. Mattos, C. and Ringe, D., International Tables for Crystallography. 2001, 623-647.
48. Sreenivasan, U. and Axelsen, P. H., Biochemistry, 1992, 31(51), 12785-12791.
49. Dunitz, J., Science, 1994, 264, 670-670.
50. Carugo, O. and Bordo, D., Acta. Cryst. D: Biol Cryst, 1999, D55(2), 479-483.
51. Katz, B.A., et al., J. Mol. Biol., 2001, 307(5), 1451-1486.
52. Katz, B.A., et al., Chem. Biol., 2001, 8(11), 1107-1121.
53. Ringe, D. and Mattos, C., Med. Res. Rev., 1999, 321-331.
54. Mattos, C. and Ringe, D., Curr. Opin. in Struct. Biol. 2001, 11(6), 761-764.
55. Mattos, C. and Ringe, D., Nature Biotechnol., 1996, 14(5), 595-599.
56. English, A.C., Groom, C. R., and Hubbard, R. E., Protein. Eng., 2001, 14(1), 47-59.
57. English, A.C., et al., Proteins: Struct. Funct. Gen., 1999, 37(4), 628-640.
58. Bartlett, P.A., et al., J. Am. Chem. Soc., 2002, 124(15), 3853-3857.
59. Ladbury, J.E., Chem. Biol., 1996, 3(12), 973-980.
60. Katz, B.A., et al., Nature, 1998, 391(6667), 608-612.
61. Katz, B.A. and Luong, C., J. Mol. Biol., 1999, 292(3), 669-684.
62. Janc, J.W., et al., Biochemistry, 2000, 39(16), 4792-4800.
63. Katz, B.A., et al., in Special Publication -Royal Society of Chemistry. 2001, 211-222.
64. Nienaber, V. L., et al., in U.S. 2001, (Abbott Laboratories, USA): US. p. 33 pp., Cont.-in-part of U.S. Ser. No. 36, 184.
65. McClellan, W. J., et al., in Abstr. Pap. -Am. Chem. Soc. 2001. p. MEDI-294.
66. Rockway, T.W., et al., in Abstr. Pap. -Am. Chem. Soc. 2000. p. MEDI-030.
67. Nienaber, V. L., et al., Structure (London), 2000, 8(5), 553-563.
68. Nienaber, V., et al., J. Biol. Chem., 2000, 275(10), 7239-7248.
69. Nienaber, V. L., et al., in PCT Int. Appl. 1999, (Abbott Laboratories, USA).: WO. p. 57.
70. Nienaber, V. L., Mersinger, L.J., and Kettner, C.A., Biochemistry, 1996, 35(30), 9690-99.
71. Nienaber, V. L., et al.,. Nature Biotech., 2000, 18(10), 1105-1108.
72. Hajduk, P. J., et al., J. Med. Chem., 2000, 43(21), 3862-3866.
73. Nienaber, V. L., Boxrud, P. D., and Berliner, L. J., J. Prot. Chem., 2000, 19(4), 327-333.
74. Dong, J., et al., Biochemistry, 2001, 40(33), 9751-9757.
75. Hajduk, P. J., et al., J. Am. Chem. Soc., 1997, 119(25), 5818-5827.
76. Fesik, S.W., et al., Protein Eng., 1997, 10(Suppl.), 73.
77. Sheppard, G. S., et al., in Book of Abstracts, 213th ACS National Meeting, San Francisco, April 13-17. 1997. p. MEDI-081.
78. Petros, A.M. and Fesik, S.W., Methods Enzymol., 1994, 239 (Nuclear Magnetic Resonance, Pt. C), 717-739.
79. Banner, D., et al., Perspect. Med. Chem. 1993, 27-43.
80. Steinmetzer, T., Hauptmann, J., and Sturzebecher, J., Expert. Opin. Investig. Drugs., 2001, 10(5), 845-864.